The 'pink blooms from among the rubble' campaign aims to educate and support women with breast cancer in Gaza, despite ongoing Israeli aggression. Al Jazeera spoke to Hiba Musbah, a breast cancer patient, about her journey.
Key points
The campaign is part of a broader effort to combat breast cancer in the region.: The campaign is part of a broader effort to combat breast cancer in the region.
The campaign is taking place amid ongoing Israeli aggression in Gaza.: The campaign is taking place amid ongoing Israeli aggression in Gaza.
Sources checked by our analysis pipeline: 1
NewsFeed
‘Pink blooms from among the rubble’: Battling breast cancer in Gaza
Health workers in Gaza are participating in a breast cancer campaign called ‘pink blooms from among the rubble’ to educate and support women with the disease amid Israel’s genocidal war. Al Jazeera spoke to breast cancer patient Hiba Musbah about her painful journey.
EXCLUSIVE: Generic versions of Ozempic are now available, marking a significant move by Dr Reddy's to address the supply issues with Obeda. The company has introduced new brands of generic Ozempic, indicating a proactive approach to mitigate the impact of the Obeda supply disruption. This move aims to ensure patients continue to access the medication they need while the issue with Obeda is resolved.
### Briefing Losing my job and getting sick have led me to reevaluate my life and make conscious decisions to fill my time meaningfully. However, the medication has some side effects, including restlessness, racing heart, and an increased need for physical activity. I have also noticed that my face has swelled up slightly, my knee joints feel weird, and my sleep is now broken, with me waking up at 5:00 or 6:00 in the morning.
Dr Reddy's, the generic drug company, has introduced new versions of the diabetes medication Ozempic, Obeda Pro and Obeda Plus, manufactured by different manufacturers. This marks a significant shift in the company's strategy, likely leading to discontinuation of supplies of the original Obeda injection due to an impurity issue. The development and launch planning for these products were already underway before the July supply disruption.